wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37027759-3B9E015C-C957-459B-A5A1-1110E4F0D484
Q37027759-3B9E015C-C957-459B-A5A1-1110E4F0D484
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37027759-3B9E015C-C957-459B-A5A1-1110E4F0D484
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
P2860
Q37027759-3B9E015C-C957-459B-A5A1-1110E4F0D484
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37027759-3B9E015C-C957-459B-A5A1-1110E4F0D484
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
667a79ad469c9ddb0bc3bf46fe4055d7b5f06d65
P2860
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R).